The aim of our study was to assess beta cell (BC) secretory response to a standardized test meal in newly diagnosed T2D subjects and to compare the effect of early short-term insulin treatment vs. glimepiride, both added to metformin, on BC function, glycemic control and lipid metabolism, during a 12-month follow-up. Here, INS is linked to type 2 diabetes mellitus.